top of page

News

At the Packard Symposium sponsored by Johns Hopkins, Dr. Smith discussed the preliminary results from the ongoing Nuedexta treatment trials as it relates to the assessment of bulbar function in ALS trials.

Dr. Smith discussed the assessment of bulbar function in ALS clinical trials at Biogen Pharmaceuticals (Boston), at the ALS Investigator Research Workshop sponsored by ALSA (Philadelphia), and again in Clearwater, Florida at the NEALS annual meeting.

© 2021 by Center for Neurologic Study.

bottom of page